𝔖 Bobbio Scriptorium
✦   LIBER   ✦

NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy

✍ Scribed by Han-Ming Shen; Vinay Tergaonkar

Publisher
Springer
Year
2009
Tongue
English
Weight
281 KB
Volume
14
Category
Article
ISSN
1360-8185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NF-κB in liver diseases: a target for dr
NF-κB in liver diseases: a target for drug therapy
✍ Pablo Muriel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

## Abstract There are five nuclear factor‐__κ__B (NF‐__κ__B) transcription factors with important roles in innate immunity, liver inflammation, fibrosis and apoptosis prevention. Several inhibitors of NF‐__κ__B, like caffeic acid, captopril, curcumin, pyrrolidine dithiocarbamate, resveratrol, silym

Blocking anti-apoptosis as a strategy fo
Blocking anti-apoptosis as a strategy for cancer chemotherapy: NF-κB as a target
✍ N.R. Monks; D.K. Biswas; A.B. Pardee 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

## Abstract Critical processes underlying cancers must be better understood to develop strategies for treatment and prevention. A chemotherapeutic strategy is proposed that is based upon re‐establishment, with a drug, of nullified programmed cell death (apoptosis) in cancer cells, which to survive

PLK1 as a potential drug target in cance
PLK1 as a potential drug target in cancer therapy
✍ Kee Chuan Goh; Haishan Wang; Niefang Yu; Yifa Zhou; Yin Zheng; ZeYi Lim; Kanda S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 1 views